Paniagua, R. T., Sharpe, O., Ho, P. P., Chan, S. M., Chang, A., Higgins, J. P., . . . Robinson, W. H. (2006). Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. American Society for Clinical Investigation.
استشهاد بنمط شيكاغوPaniagua, Ricardo T., et al. Selective Tyrosine Kinase Inhibition By Imatinib Mesylate for the Treatment of Autoimmune Arthritis. American Society for Clinical Investigation, 2006.
MLA استشهادPaniagua, Ricardo T., et al. Selective Tyrosine Kinase Inhibition By Imatinib Mesylate for the Treatment of Autoimmune Arthritis. American Society for Clinical Investigation, 2006.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.